1364165-08-1

Basic information

• Product Name: 7-(2,4-Dichloro-benzenesulfonylamino)-5,6,7,8-tetrahydro-naphthalene-2-carboxylic acid hydroxyamide
• Synonyms: 7-(2,4-Dichloro-benzenesulfonylamino)-5,6,7,8-tetrahydro-naphthalene-2-carboxylic acid hydroxyamide
• CAS NO: 1364165-08-1
• Molecular Weight: 415.297
• Mol File: 1364165-08-1.mol

Chemical Properties

• CAS DataBase Reference: 7-(2,4-Dichloro-benzenesulfonylamino)-5,6,7,8-tetrahydro-naphthalene-2-carboxylic acid hydroxyamide(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(2,4-Dichloro-benzenesulfonylamino)-5,6,7,8-tetrahydro-naphthalene-2-carboxylic acid hydroxyamide(1364165-08-1)
• EPA Substance Registry System: 7-(2,4-Dichloro-benzenesulfonylamino)-5,6,7,8-tetrahydro-naphthalene-2-carboxylic acid hydroxyamide(1364165-08-1)

Safety Data

• Hazardous Substances Data: 1364165-08-1(Hazardous Substances Data)

Upstream product

• 1364166-11-9 C₁₈H₁₇Cl₂NO₄S 
• 885280-71-7 7-bromo-1,2,3,4-tetrahydro-naphthalen-2-ylamine 
• 1364165-70-7 tert-butyl N-(7-bromotetralin-2-yl)carbamate 
• 1355592-51-6 methyl 3-aminotetralin-6-carboxylate hydrochloride 
• 1355592-60-7 methyl 3-(tert-butoxycarbonylamino)tetralin-6-carboxylate 
• 132095-54-6 7-bromo-2-tetralone 

Relevant articles and documents

NOVEL N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, ester or stereoisomer thereof, wherein R1 to R3 and X have the significances given herein. The present invention is also directed to proc

NOVEL N-HYDROXY-BENZAMIDS FOR THE TREATMENT OF CANCER

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, ester or stereoisomer thereof, wherein R1 to R3 and X have the significances given herein. The present invention is also directed to proc